HIV-1 Diagianostic Service

---

Expert Virus Testing in Biological Materials

Background

Test Specifications

Report - Confidentiality Notice

Sample Preparation

Shipping Instructions

Please Note

Background 

The use of human material in the production of biopharmaceutical products represents a potential contamination risk. Without proper control it could potentially introduce infectious agents such as the HIV-1 virus to the production process. Hence, HIV-1 viral load monitoring is as an integral component in the process of manufacturing and purification of biopharmaceutical or biotechnology products derived from human samples.

Test Specifications 

Our HIV-1 Diagnostic Service uses an in vitro nucleic acid amplification test for the quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in bio-pharmaceutical samples. Viral RNA is extracted from the material and is treated with reverse transcriptase so that the RNA of the virus is transcribed into DNA. Conventional PCR is used to amplify a specific region of the DNA. The amplicons are detected by subsequent agarose gel-electrophoresis.

Report - Confidentiality Notice 

• Test result is provided in advance via fax when desired
• Additional report with a printout of the gel photo is provided
• All customer information is treated as strictly confidential
• Formal, contractual confidentiality agreements can be generated upon request
• Reports are maintained in our archives for five years; samples are kept up to six months for retesting at customers' request

Sample Preparation and Shipping Instructions 

Please find a detailed description of the sample preparation on the sample submission form. For more detailed information contact our support team: support@minerva-biolabs.com.

Please Note  

Minerva Biolabs does not accept sample material of biological safety level 3 or 4 or with known HIV-1 load. The offered HIV-1 testing service is not to be used for clinical diagnosis.